Medtech firm Biolidics' shares slump in Catalist debut
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SHARES of medical technology company Biolidics slumped on their trading debut on the Catalist board, with the stock closing down 16 per cent from its listing price of S$0.28.
The stock opened at S$0.265 on Wednesday morning, and drifted lower through the trading day. It closed at S$0.235, with 4.88 million shares changing hands.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Vietnam acts fast to shield firms, households from fuel price surge
Beijing’s calculated silence on the Iran war
S-E Asia tourism takes hit from Middle East crisis, but intra-regional travel could spell hope
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
